| HGNC Family | Non-coding RNAs |
| Name | microRNA 4728 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe HER2 locus is now recognized as a bi‐functional unit that encodes both the well‐known membrane receptor and the intronic microRNA miR-4728, which functions as a versatile regulator in various disease contexts. In rheumatoid arthritis, for instance, miR-4728-5p downregulates PADI2—a newly identified risk gene—thereby emerging as a potential therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In cancer, miR-4728 assumes complex roles. In breast cancer, one study demonstrated that miR-4728 acts as a negative regulator of MAPK signaling by directly targeting the ERK upstream kinase MST4, thus exerting tumor-suppressive effects."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Meanwhile, alternative targeting mechanisms have been identified: miR-4728-3p can use either a canonical seed (nucleotides 2–8) or a shifted internal seed (nucleotides 6–12) to regulate expression of estrogen receptor α, linking two major biomarkers in breast cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, in HER2-amplified breast cancers, miR-4728 targets ESR1 mRNA, leading to reduced NOXA expression and contributing to resistance against HER2 inhibitors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional research has further elucidated the multifaceted regulatory roles of miR-4728. Its co-expression with HER2 has been confirmed in several cell lines and tissue samples, underlining its close relationship with its host oncogene."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Interestingly, miR-4728-3p also exerts oncogenic influence by stabilizing miR-21-5p via inhibition of the non-canonical poly(A) polymerase PAPD5, thereby reinforcing HER2-driven oncogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Beyond its role in cancer, miR-4728-5p has been implicated in non-neoplastic processes; for example, in age-related cataract, overexpression of this miRNA leads to downregulation of the DNA repair gene OGG1 through a regulatory axis involving a long noncoding RNA, which may exacerbate oxidative DNA damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In colorectal cancer, reduced levels of miR-4728-5p were observed alongside perturbations in transcription factor networks, suggesting its involvement in tumor development."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Finally, in breast cancer, a feedback loop in which miR-4728-5p directly targets EBP1 to increase HER2 expression has been shown to promote cell proliferation and migration, further highlighting its role in oncogenic signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yukinori Okada, Tomoki Muramatsu, Naomasa Suita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Significant impact of miRNA-target gene networks on genetics of human complex traits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep22223"}], "href": "https://doi.org/10.1038/srep22223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26927695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26927695"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "D C Schmitt, L Madeira da Silva, W Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2015.116"}], "href": "https://doi.org/10.1038/cddis.2015.116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25950472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25950472"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Inga Newie, Rolf Søkilde, Helena Persson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interaction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0097200"}], "href": "https://doi.org/10.1371/journal.pone.0097200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24828673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24828673"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Konstantinos V Floros, Timothy L Lochmann, Bin Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coamplification of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-4728"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " protects "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "HER2"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": "-amplified breast cancers from targeted therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1717820115"}], "href": "https://doi.org/10.1073/pnas.1717820115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29476008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29476008"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hai Li, Xin Zhou, Jun Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-4728-3p could act as a marker of HER2 status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-150524"}], "href": "https://doi.org/10.3233/CBM-150524"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26406406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26406406"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Inga Newie, Rolf Søkilde, Helena Persson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep35664"}], "href": "https://doi.org/10.1038/srep35664"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27752128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27752128"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Tianqiu Zhou, Junfang Zhang, Bai Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA NONHSAT143692.2 is involved in oxidative DNA damage repair in the lens by regulating the miR‑4728‑5p/OGG1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2020.4707"}], "href": "https://doi.org/10.3892/ijmm.2020.4707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33000245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33000245"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "T Gurer, A Aytekin, E Caki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol (Mosk) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.31857/S0026898422030077"}], "href": "https://doi.org/10.31857/S0026898422030077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35621109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35621109"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yu Zhou, Yuan Yuan, Liuyi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0245832"}], "href": "https://doi.org/10.1371/journal.pone.0245832"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33529238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33529238"}]}]}]}
|
| NCBI Gene ID | 100616132 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR4728 has 431 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 10 datasets.
Click the + buttons to view associations for MIR4728 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR4728 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR4728 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR4728 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4728 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR4728 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR4728 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR4728 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MIR4728 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR4728 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR4728 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |